Jonathan Wogel

Chief Executive Officer

Jonathan has over 35 years global pharma, device & biotech M&A, JV licensing and scale up experience, with over 26 years as an expat. He has developed over £4Bn in M&A deals for private and PE backed businesses and launched/licenced over 50 products globally.

The last 12 years have been focused on helping SMEs and startups with seed/Series A, B and Angel/PE based fundraising by developing and implementing business and commercial strategies to drive scale.

Jonathan has an undergraduate degree in Biochemistry and also holds a MBA, MPH and a PhD (Health Economics) He is also the Executive Chair & a Director of Zentraxa, a biomaterials spin out from the University of Bristol.